Search results for abx831347

Trevogrumab, Abbexa, abx831347

Trevogrumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MSTN/GDF8, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Trevogrumab is under investigation in clinical trial NCT02943239 (Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men).